Phreesia (NYSE:PHR) Shares Gap Down Following Weak Earnings

Shares of Phreesia, Inc. (NYSE:PHR) gapped down before the market opened on Thursday following a dissappointing earnings announcement. The stock had previously closed at $11.85, but opened at $11.02. Phreesia shares last traded at $11.2050, with a volume of 151,610 shares.

The company reported $0.03 earnings per share for the quarter, missing the consensus estimate of $0.09 by ($0.06). The firm had revenue of $129.46 million for the quarter, compared to analyst estimates of $129.06 million. Phreesia had a net margin of 1.85% and a return on equity of 5.13%. The company’s revenue was up 10.4% compared to the same quarter last year. During the same period last year, the business earned $0.01 EPS.

Key Phreesia News

Here are the key news stories impacting Phreesia this week:

• Positive Sentiment: Management maintained fiscal 2027 revenue guidance of $510 million to $520 million, broadly in line with Wall Street expectations, reducing the risk of a near-term outlook cut. Phreesia maintains FY2027 revenue outlook
• Positive Sentiment: Phreesia reported positive operating and free cash flow for the quarter and reduced debt principal by more than $23 million, supporting balance-sheet improvement and potentially lowering future interest costs. Phreesia Announces Second Quarter Fiscal 2027 Results
• Positive Sentiment: Management identified AccessOne as a multi-year growth opportunity, giving investors an additional potential driver beyond the company’s core revenue expansion. Needham & Company also initiated or reiterated a Buy rating, adding analyst support. Needham Buy Rating
• Neutral Sentiment: The quarter’s revenue growth and profitability expansion were described as in line with expectations, suggesting execution remains steady but did not produce a major upside surprise. Phreesia Q2 2027 Earnings Call Transcript
• Negative Sentiment: Adjusted earnings were materially below consensus at $0.03 per share versus the expected $0.09-$0.11. The miss may limit upside for PHR despite the revenue beat and maintained full-year outlook. Phreesia Q2 Earnings and Revenues Lag Estimates

Analyst Upgrades and Downgrades

PHR has been the subject of several recent research reports. Truist Financial increased their price target on Phreesia from $11.00 to $12.00 and gave the company a “hold” rating in a research note on Thursday, May 28th. Weiss Ratings raised Phreesia from a “sell (d)” rating to a “sell (d+)” rating in a research note on Monday, July 20th. Citigroup reiterated a “market perform” rating on shares of Phreesia in a report on Friday, May 29th. Needham & Company LLC reissued a “buy” rating and set a $14.00 target price on shares of Phreesia in a research report on Monday. Finally, Royal Bank Of Canada reissued an “outperform” rating and set a $19.00 target price on shares of Phreesia in a research report on Thursday. Nine equities research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $16.29.

Institutional Trading of Phreesia

Large investors have recently bought and sold shares of the business. EverSource Wealth Advisors LLC raised its position in shares of Phreesia by 1,119.8% in the 1st quarter. EverSource Wealth Advisors LLC now owns 3,269 shares of the company’s stock worth $27,000 after acquiring an additional 3,001 shares in the last quarter. Van ECK Associates Corp lifted its stake in shares of Phreesia by 78.7% in the 4th quarter. Van ECK Associates Corp now owns 2,502 shares of the company’s stock valued at $42,000 after purchasing an additional 1,102 shares during the period. New York State Teachers Retirement System bought a new stake in shares of Phreesia during the 1st quarter valued at about $44,000. Rockefeller Capital Management L.P. boosted its position in shares of Phreesia by 354.6% during the 4th quarter. Rockefeller Capital Management L.P. now owns 2,755 shares of the company’s stock valued at $47,000 after purchasing an additional 2,149 shares in the last quarter. Finally, Allworth Financial LP acquired a new stake in Phreesia during the second quarter worth approximately $58,000. 92.10% of the stock is currently owned by institutional investors and hedge funds.

Phreesia Stock Performance

The firm has a market capitalization of $696.10 million, a P/E ratio of 74.30 and a beta of 0.86. The stock has a fifty day simple moving average of $11.19 and a two-hundred day simple moving average of $10.48. The company has a debt-to-equity ratio of 0.41, a current ratio of 1.76 and a quick ratio of 1.76.

Phreesia Company Profile

Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.